Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Atara Biotherapeutics (ATRA) Revenue (2022 - 2025)

Historic Revenue for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $3.5 million.

  • Atara Biotherapeutics' Revenue fell 9140.83% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $151.9 million, marking a year-over-year increase of 5126.59%. This contributed to the annual value of $128.9 million for FY2024, which is 140402.43% up from last year.
  • As of Q3 2025, Atara Biotherapeutics' Revenue stood at $3.5 million, which was down 9140.83% from $17.6 million recorded in Q2 2025.
  • Over the past 5 years, Atara Biotherapeutics' Revenue peaked at $98.1 million during Q1 2025, and registered a low of $221000.0 during Q4 2022.
  • Its 4-year average for Revenue is $21.4 million, with a median of $7.3 million in 2022.
  • Per our database at Business Quant, Atara Biotherapeutics' Revenue tumbled by 9814.46% in 2023 and then skyrocketed by 289268.55% in 2024.
  • Atara Biotherapeutics' Revenue (Quarter) stood at $221000.0 in 2022, then skyrocketed by 1823.98% to $4.3 million in 2023, then soared by 670.3% to $32.8 million in 2024, then tumbled by 89.46% to $3.5 million in 2025.
  • Its last three reported values are $3.5 million in Q3 2025, $17.6 million for Q2 2025, and $98.1 million during Q1 2025.